349 related articles for article (PubMed ID: 29475448)
1. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
3. Effects of Jitai tablet, a traditional Chinese medicine, on spontaneous withdrawal symptoms and modulation of dopaminergic functions in morphine-dependent rats.
Tu S; Gao J; Liu J; Zhang J; Huang Y; Xu S; Han M; Liang J
Phytother Res; 2015 May; 29(5):687-94. PubMed ID: 25626992
[TBL] [Abstract][Full Text] [Related]
4. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
Achat-Mendes C; Anderson KL; Itzhak Y
Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
Gou H; Wen D; Ma C; Li M; Li Y; Zhang W; Liu L; Cong B
Behav Brain Res; 2015 Apr; 283():87-96. PubMed ID: 25629941
[TBL] [Abstract][Full Text] [Related]
7. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.
Granado N; Ares-Santos S; O'Shea E; Vicario-Abejón C; Colado MI; Moratalla R
Neurotox Res; 2010 Jul; 18(1):48-58. PubMed ID: 19760475
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effects of Jitai Tablet, a Traditional Chinese Medicine, on the MPTP-Induced Acute Model of Parkinson's Disease: Involvement of the Dopamine System.
Liu J; Gao J; Tu S; Xu S; Liu Y; Shang W; Gu C; Huang Y; Han M
Evid Based Complement Alternat Med; 2014; 2014():542383. PubMed ID: 24799940
[TBL] [Abstract][Full Text] [Related]
9. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
10. Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity.
Wang L; Wang Z; Xu X; Zhu R; Bi J; Liu W; Feng X; Wu H; Zhang H; Wu J; Kong W; Yu B; Yu X
Int J Med Sci; 2017; 14(4):340-347. PubMed ID: 28553166
[TBL] [Abstract][Full Text] [Related]
11. Neonatal methamphetamine in the rat: evidence for gender-specific differences upon tyrosine hydroxylase enzyme in the dopaminergic nigrostriatal system.
Gomes-da-Silva J; Perez-Rosado A; de Miguel R ; Fernandez-Ruiz J; Silva MC; Tavares MA
Ann N Y Acad Sci; 2000 Sep; 914():431-8. PubMed ID: 11085342
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
[TBL] [Abstract][Full Text] [Related]
13. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
Itzhak Y; Gandia C; Huang PL; Ali SF
J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic Neuron-Specific Deletion of p53 Gene Attenuates Methamphetamine Neurotoxicity.
Lu T; Kim PP; Greig NH; Luo Y
Neurotox Res; 2017 Aug; 32(2):218-230. PubMed ID: 28342134
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator is not involved in methamphetamine-induced neurotoxicity.
Fukakusa A; Mizoguchi H; Koike H; Nabeshima T; Takuma K; Yamada K
J Pharmacol Sci; 2008 Feb; 106(2):321-4. PubMed ID: 18277051
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine.
Chen H; Wu J; Zhang J; Fujita Y; Ishima T; Iyo M; Hashimoto K
Psychopharmacology (Berl); 2012 Jul; 222(1):37-45. PubMed ID: 22200890
[TBL] [Abstract][Full Text] [Related]
17. 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine.
Ren Q; Zhang JC; Ma M; Fujita Y; Wu J; Hashimoto K
Psychopharmacology (Berl); 2014 Jan; 231(1):159-66. PubMed ID: 23934209
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity to dopamine neurons after the serial exposure to alcohol and methamphetamine: Protection by COX-2 antagonism.
Blaker AL; Rodriguez EA; Yamamoto BK
Brain Behav Immun; 2019 Oct; 81():317-328. PubMed ID: 31228610
[TBL] [Abstract][Full Text] [Related]
19. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
Chapman DE; Hanson GR; Kesner RP; Keefe KA
J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
Itzhak Y; Martin JL; Ali SF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
